REFERENCES
- van den Boom G, Rutten-van Molken M P, Molema J, Tirimanna P R, van Weel C, van Schayck C P. The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program. Am J Respir Crit Care Med 2001; 164(11):2057–2066. [PUBMED], [INFOTRIEVE], [CSA]
- Cook D, Guyatt G, Wong E, Goldstein R, Bedard M, Austin P, Ramsdale H, Jaesche R, Sears M. Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163(1):85–90. [PUBMED], [INFOTRIEVE], [CSA]
- Green R H, Singh S J, Williams J, Morgan M D. A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2001; 56(2):143–145. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Neder J A, Sword D, Ward S A, Mackay E, Cochrane L M, Clark C J. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57(4):333–337. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Guyatt G H, Berman L B, Townsend M, Pugsley S O, Chambers L W. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42(10):773–778. [PUBMED], [INFOTRIEVE]
- Berry M J, Rejeski W J, Adair N E, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999; 160(4):1248–1253. [PUBMED], [INFOTRIEVE], [CSA]
- Mahler D A, Wire P, Horstman D, Chang C N, Yates J, Fischer T, Shah T. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(8):1084–1091. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ries A L, Kaplan R M, Myers R, Prewitt L M. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med 2003; 167(6):880–888. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- http://www.atsqol.org/crq.asp, In.
- Rutten-van Molken M, Roos B, Van Noord J A. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999; 54(11):995–1003. [PUBMED], [INFOTRIEVE]
- Wijkstra P J, TenVergert E M, Van Altena R, Otten V, Postma D S, Kraan J, Koeter G H. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 1994; 49(5):465–467. [PUBMED], [INFOTRIEVE]
- Morgan M D. Experience of using the CRQ (Chronic Respiratory Questionnaire). Respir Med 1991; 85(suppl B):23–24, discussion 33–37. [PUBMED], [INFOTRIEVE]
- Tu S P, McDonell M B, Spertus J A, Steele B G, Fihn S D. A new self-administered questionnaire to monitor health-related quality of life in patients with COPD. Ambulatory Care Quality Improvement Project (ACQUIP) Investigators. Chest 1997; 112(3):614–622. [PUBMED], [INFOTRIEVE]
- Jones P W. Issues concerning health-related quality of life in COPD. Chest 1995; 107(5 suppl):187S–193S. [PUBMED], [INFOTRIEVE]
- Schünemann H J, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Austin P, Guyatt G H. A comparison of the original chronic respiratory questionnaire with a standardized version. Chest 2003; 124(4):1421–1429. [CROSSREF]
- Schünemann H, Goldstein R, Mador J, McKim D, Stahl E, Griffith L, Puhan M, Grant B JB, Austin P, Collins R, Guyatt G H. A randomized controlled trial to evaluate the self-administered standardized CRQ. Eur Respir J 2005; 25(1):31–40. [CROSSREF]
- Puhan M, Behnke M, Laschke M, Lichtenschopf A, Brändli O, Guyatt G H, Schünemann H J. Self-administration and interviewer-administration of the chronic respiratory questionnaire: a randomized trial in three German-speaking countries. Respir Med 2004; 98(4):342–350. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Williams J E, Singh S J, Sewell L, Guyatt G H, Morgan M D. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax 2001; 56(12):954–959. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Williams J E, Singh S J, Sewell L, Morgan M D. Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax 2003; 58(6):515–518. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Puhan M, Behnke M, Frey M, Grueter T, Brändli O, Lichtenschopf A, Guyatt G H, Schünemann H J. Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies. Health Qual Outcomes 2004; 2:1. [CROSSREF]
- Wyrwich K W, Fihn S D, Tierney W M, Kroenke K, Babu A N, Wolinsky F D. Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease. An expert consensus panel report. J Gen Intern Med 2003; 18(3):196–202. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wyrwich K W, Tierney W M, Wolinsky F D. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999; 52(9):861–873. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(4):1185–1189. [PUBMED], [INFOTRIEVE], [CSA]
- Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(3 Pt 1):785–790. [PUBMED], [INFOTRIEVE], [CSA]
- Jaeschke R, Guyatt G H, Keller J, Singer J. Interpreting changes in quality-of-life score in N of 1 randomized trials. Control Clin Trials 1991; 12(4 suppl):226S–233S. [PUBMED], [INFOTRIEVE]
- Jaeschke R, Singer J, Guyatt G H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10(4):407–415. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Juniper E F, Guyatt G H, Willan A, Griffith L E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994; 47(1):81–87. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guyatt G H, Osoba D, Wu A W, Wyrwich K W, Norman G R. Clinical significance consensus meeting G. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002; 77(4):371–383. [PUBMED], [INFOTRIEVE], [CSA]
- Lassere M N vdHD, Johnson K R. Foundations of the minimal clinically important difference for imaging. J Rheumatol 2001; 28:890–891. [PUBMED], [INFOTRIEVE]
- Schünemann H, Griffith L, Jaeschke R, Stubbing D, Goldstein R, Guyatt G H. Evaluation of the minimal important difference for the feeling thermometer and St. Georges Respiratory questionnaire in patients with chronic airflow limitation. J Clin Epidemiol 2003; 56(12):1170–1176. [CSA], [CROSSREF]
- Guyatt G H, Norman G R, Juniper E F, Griffith L E. A critical look at transition ratings. J Clin Epidemiol 2002; 55(9):900–908., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Redelmeier D A, Guyatt G H, Goldstein R S. Assessing the minimal important difference in symptoms: a comparison of two techniques [see comments]. J Clin Epidemiol 1996; 49(11):1215–1219. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Larson J L, Covey M K, Wirtz S E, Berry J K, Alex C G, Langbein W E, Edwards L. Cycle ergometer and inspiratory muscle training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(2):500–507. [PUBMED], [INFOTRIEVE], [CSA]
- Harper R, Brazier J E, Waterhouse J C, Walters S J, Jones N M, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax 1997; 52(10):879–887. [PUBMED], [INFOTRIEVE]
- Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt G H, Goldstein R S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002; 3:CD003793. [PUBMED], [INFOTRIEVE]
- Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Ikeda A, Mishima M. Health status measured with the CRQ does not predict mortality in COPD. Eur Respir J 2002; 20(5):1147–1151. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gerardi D A, Lovett L, Benoit-Connors M L, Reardon J Z, ZuWallack R L. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J 1996; 9(3):431–435. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Redelmeier D A, Guyatt G H, Goldstein R S. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996; 49(11):1215–1219. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van den Boom G, Rutten-van Molken M P, Tirimanna P R, van Schayck C P, Folgering H, van Weel C. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J 1998; 11(1):67–72. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
- Schünemann H, Stahl E, Mador J, McKim D, Stubbing D, Goldstein R, Guyatt G H. Validation of a self-administered, standardized version of the Chronic Respiratory Questionnaire (CRQ). Am J Respir Crit Care Med 2003; 167:A226.
- Guyatt G, Montori V, Devereaux P J, Schunemann H, Bhandari M. Patients at the center: in our practice, and in our use of language. ACP J Club 2004; 140(1):A11–A12. [PUBMED], [INFOTRIEVE]
- Schünemann H, Goldstein R, Mador J, McKim D, Stahl E, Griffith L, Austin P, Guyatt G H. Relative responsiveness of health related quality of life instruments in COPD. Submitted.